歌礼制药-B(01672)股东将股票存入渣打银行(香港) 存仓市值11.29亿港元

Group 1 - The core point of the article is that Gilead Sciences-B (01672) has deposited shares worth HKD 1.129 billion into Standard Chartered Bank (Hong Kong), representing 6.93% of its total shares [1] - Gilead Sciences-B announced that its board has selected its first oral amylin receptor agonist peptide, ASC36 oral tablets, for clinical development [1] - The company expects to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for ASC36 oral tablets for the treatment of obesity in the second quarter of 2026 [1]